Détails du produit
Synonyms
ERBB2, CD340, HER-2, neu, HER2, MLN19, NEU, NGL, TKR1
Source
Rabbit Her2, His Tag (HE2-R52H8) is expressed from human 293 cells (HEK293). It contains AA Thr 23 - Thr 652 (Accession # G1SZL0-1).
Predicted N-terminus: Thr 23
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 71.0 kDa. The protein migrates as 85-95 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>95% as determined by SDS-PAGE.
>95% as determined by SEC-MALS.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Shipping and Storage
This product is shipped at ambient temperature.
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Les clients ont également consulté
Affichage des données
SDS-PAGE

Rabbit Her2, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.
SEC-MALS

The purity of Rabbit Her2, His Tag (Cat. No. HE2-R52H8) is more than 95% and the molecular weight of this protein is around 70-105 kDa verified by SEC-MALS.
Report
Bioactivity-ELISA

Immobilized Rabbit Her2, His Tag (Cat. No. HE2-R52H8) at 1 μg/mL (100 μL/well) can bind Pertuzumab Biosimilar with a linear range of 0.2-6 ng/mL (QC tested).
Protocol
Avis des utilisateurs Publier un commentaire

Introduction de fond
Progrès de frontière
- Nom anglais:
Receptor protein-tyrosine kinase erbB-2
- Catégorie:
- Nombre de médicaments répertoriés:
47 Détails
- Nombre de médicaments cliniques:
238 Détails
- Étape de développement la plus élevée:
Approved



















